NEJM: Potential Stage 2 CRC Biomarker for Chemotherapy Use

[DK37]

A potentially very important new finding showing a biomarker that appears predictive of Stage 2 patients that would significantly benefit from chemotherapy. Findings were based upon retrospective analysis, prospective clinical trials have not been done yet. First link = news article. Second link = article from the New England Journal of Medicine. http://www.medscape.com/viewarticle/857470 and http://www.nejm.org/doi/full/10.1056/NEJMoa1506597

-DK

[Nik Colon]

Just wanted to say hi, and thanks again for all your info. I see you're keeping your list updated Thanks again for all you do.

Nik

[DK37]

Just wanted to say hi, and thanks again for all your info. I see you're keeping your list updated Thanks again for all you do.

Nik

Hi Nik! I thought of you this morning when I was adding this link to my list you started!

-DK

[Nik Colon]

Just wanted to say hi, and thanks again for all your info. I see you're keeping your list updated Thanks again for all you do.

Nik

Hi Nik! I thought of you this morning when I was adding this link to my list you started!

-DK

hope you are doing well

[orcasres]

DK,

Thanks so much for posting this. I was staged IIA but I got adjuvant chemo because my tumor was medullary which is rare and I had lymphovascular invasion. The medullary tumor was the driver. I just pulled my pathology report and I was CDX2 positive. While I have a number of residual side effects from the chemo and I wanted to take every step I could to keep the disease from returning (I never regretted doing it), I wonder with this study if it would have been recommended. I am thrilled to see this kind of research. It certainly seems like it will put another tool in the box for stage II folks.

Lois